Patent · US Active

Porphyrin modified telodendrimers

US10238750B2 · kind B2 · utility

2Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2013
Grant dateMar 26, 2019
Priority date
Expiry dateAug 3, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N5/062
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides amphiphilic telodendrimers that aggregate to form nanocarriers characterized by a hydrophobic core and a hydrophilic exterior. The nanocarrier core may include amphiphilic functionality such as cholic acid or cholic acid derivatives, and the exterior may include branched or linear poly(ethylene glycol) segments. Nanocarrier cargo such as hydrophobic drugs and other materials may be sequester in the core via non-covalent means or may be covalently bound to the telodendrimer building blocks. Telodendrimer structure may be tailored to alter loading properties, interactions with materials such as biological membranes, and other characteristics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.